The investigation led four genes into our sight — SLC25A22, TUBB6, MYEF2 and PARM1. Data have shown that these genes ensure the sample classification with the accuracy of more than 70% and the genes are annotated to cancer-relevant functions/pathways. This evidence concerns the gene SLC25A22 and cancer.